Pediatric AKI and Application of Biomarkers

Size: px
Start display at page:

Download "Pediatric AKI and Application of Biomarkers"

Transcription

1 Pediatric AKI and Application of Biomarkers Arnold O. Beckman Conference Michael Zappitelli MD, MSc Most AKI is ATN and multifactorial Glomerular Tubular Vascular Interstitial Child AKI disease model Community AKI? Surgery Emergency Wards Day Hospitals AKI? PICU AKI Increased outcome risk Mortality?Long Term CKD Non ICU AKI?Severity?Risk Factors Short/Long term impact? 1

2 Overview 1. Pediatric AKI common and associated with poor outcomes 2. Opportunities for AKI biomarkers in children 3. Review of some published pediatric AKI biomarker data 4. Future directions 1. Pediatric AKI common and associated with poor outcomes 2. Opportunities for AKI biomarkers in children 3. Review of some published pediatric AKI biomarker data 4. Future directions Overview Definition in children Acute SCr rise Acute UO drop KDIGO Refining timing of rise 2

3 Incidence of RRT AKI ~1% ~1-3% ~6% 5-6% 1-2% ~4% RRT AKI Mortality high everywhere 50-60% 40-45% 25-50% 42-67% 52-77% 33-65% 40% 64% 36% 11% AKI child populations At risk Pre operative cardiac Sx Clinical data collection ICU Admission Aminoglycoside start Chemotherapy start Blood collection Urine collection Follow up 3

4 Incidence: PICU full cohort studies Turkey N=189 No severe CKD Creat USA N=3396 No severe CKD Creat ~40% ~10% Kayaz et al, Acta Pediatr, 2012 Schneider et al, Ped Crit Care, 2010 Incidence: PICU partial cohort studies Canada N= hours Creat USA ~18% N=150 Vent and/or Vaso, Foley Alkandari et Creat al, Crit + Urine Care, 2011 ~80% Ackan-Arikan, Ped Crit Care, 2007 Plotz et al, Intens Care Med, 2008 ~60% Netherlands North India N=189 N=486 Vent >24 4 hours, days NO Creat severe + Admx Urine AKI ~20% South Creat India N=215 >48 hours Creat + Urine Mehta, et al, Ind Ped, 2012 ~30% Krishnamoorthy, et al, Ind J Ped, 2012 AKI OCCURS EARLY IN THE ICU Confirmed in several other larger epidemiologic cohort studies 4

5 Does a 50% SCr rise really matter? In repeated studies last 5 years: AKI independently associated with PICU mortality Length of stay Duration Confirmed: of mechanical several ventilation retrospective and prospective PICU studies Graded AKI response: associated with: Stage 1 worse than 2 worse than 3 PICU LOS Hospital LOS Longer ventilation Difficult to REALLY know if independent of illness severity Incidence: Cardiac 2 Canadian studies (646) Morgan, j Ped, 2012 Zappitelli, KI, Hungarian study (1510) Toth, Card Anethes, US studies (1594) Manrique, Ped Anesth, 2009 Li, Crit Care Med, 2011 Aydin, Ann Thorac Surg, 2012 Blinder, J Thor Card Surg, Indian study (124) Sethi, Clin Exp Nephrol, 2011 Day of Occurrence of AKI Number of patients Adults Children 0 Day 1 Day 2 Day 3 Day 4 Day 5 + First Day from surgery that AKI first appeared 5

6 Does a 50% SCr rise really matter? Neonatal cardiac Does a 50% SCr rise really matter? TRIBE-AKI, multi-centre cardiac: Li et al, CCM 2011 Infant cardiac surgery Mammen group, Pediatr Nephrol, 2013 AKIN Stage 3: Longer Longer stay PICU stay Prolonged Mortality ventilation Cardiac surgery setting Zappitelli, Pediatr Nephrol,

7 Cardiopulmonary bypass time and risk of AKI Patients developing acute kidney injury 80% 70% 60% 50% 40% 30% 20% 10% Adj OR: 1 Adj OR: 2.14 (0.97, 4.72) Adj OR: 2.47 (1.08, 5.65) Adj OR: 3.20 (1.38, 7.44) Adj OR: 7.57 (2.62, 21.92) 0% >180 Bypass time (minutes) Adjusted for age, RACHS 1 score and site AKI (or recognition) may be increasing Comparison of the incidences of general pediatric admissions and ARF cases according to year Vachvanichsanong et al, Pediatrics, 2006 THAILAND Community acquired AKI in children Prospective observation cohort of children admitted to the Texas Children's Hospital ED Jan Apr 2009 Serum creatinine an urine ordered? Consent obtained? Included: n=252 Only 27% had baseline SCr available 7% had AKI defined by prifle criteria 7

8 What do we know about non ICU AKI? 5% 25% Incidence: Nephrotoxins Aminoglycosides 5 days N=557 Increasing numbers ( 3) of NTM used Increases risk for AKI in non ICU children Moffett & Goldstein, CJASN, 2011 Zappitelli et al, NDT, 2011 Confirmed MCH prospective study (n~160) 40% Does a 50% SCr rise really matter? Houston AG cohort ( 5days): AKI associated with longer LOS & costs Zappitelli et al, NDT,

9 Acute renal damage with cancer therapy Chemotherapies Cisplatin, Ifosfamide, CsA? Stem cell transplant Myeloablation, Irradiation, Post-immunosuppresion, GVHD? Infection Sepsis, ABx Kidney attack TTP TLS Acute renal damage with cancer therapy AKI post stem-cell transplant: ~20%, wide range Acute renal damage with cancer therapy 11/11/12 9

10 Zappitelli et al, ASN poster, 2012 SCr monitoring Rx's 11 days: 1/5 Rx days It is possible to DOUBLE SCr monitoring by ticking off a box! Routinely drawn SCr's per day of AG treatment Houston Montreal 1 SCr per day 16% 30% 1 SCr/2 days 26% 48% 1 SCr/3 days 41% 57% 1 SCr/4 days 48% 60% Overview 1. Pediatric AKI common and associated with poor outcomes 2. Opportunities for AKI biomarkers in children 3. Review of some published pediatric AKI biomarker data 4. Future directions AKI child populations At risk Pre operative cardiac Sx Clinical data collection ICU Admission Aminoglycoside start Chemotherapy start Blood collection Urine collection Follow up 10

11 TRIBE AKI cardiac surgery Early diagnosis Pre operative Consider clinical risk models Immediate post operative Consider pre op & intra op clinical risk models Prognosis At the time of AKI Severity of renal injury Pre operative AKI prediction: SCr, CysC, egfr Pre-op clinical model: Age, gender, RACHS-1, CPB time, study site. AKI AUC = 0.73 (0.67, 0.80) Stage 2+ AKI AUC = 0.79 (0.70, 0.87) Pre operative AKI prediction: CysC, egfr in children not predictive OR * * Pre op CysC egfr 0 Stage 1+ Stage 2+ 11

12 GFR in children not simple TRIBE AKI cardiac surgery Early diagnosis Pre operative Consider clinical risk models Immediate post operative Consider pre op & intra op clinical risk models Prognosis At the time of AKI Severity of renal injury Post operative AKI prediction: early SCr rise IL-18 ungal pngal 12

13 Post operative AKI prediction: NGAL & IL 18 IL-18 ungal pngal How have biomarkers been doing? Mishra et al, Lancet, 2005 Single centre, cardiac Parikh et al, JASN, 2012 Multi-centre, cardiac Post operative AKI prediction: NGAL & IL 18: added value 13

14 14

15 15

16 Non cardiac PICU setting Much more challenging No pre-operative assessment Many patients arrive with AKI: mild, moderate or severe Many patients arrive with high SCr not all AKI. Biomarkers may help distinguish: but who to measure in? How have biomarkers been doing? Very high risk PICU: 80% AKI Zappitelli et al, CCM, 2007 Lower risk PICU: ~40% AKI Zappitelli et al, unpublished WHAT HAPPENED? Biomarker Day 1 2 ICU AKI AUC Urine NGAL 0.61 ( ) UrineIL ( ) Urine KIM ( ) 16

17 Nephrotoxicity 17

18 Nephrotoxicity Zappitelli et al, ASN poster, 2012 Children treated with Tobramycin Pi-GST on the 1 st day of AKI AUC = % CI Focus is on QUICK and SIMPLE assessment Intent is to have an index / threshold risk with HIGH NPV No Renal Angina: HIGHLY likely NOT to develop AKI Do NOT study biomarker performance Do NOT use biomarkers to predict AKI (future) Putting it to the test! At risk PICU day 1 RA yes or no? PICU day 3 Outcome: Sever AKI (St 2) 18

19 19

20 AKI scenarios At risk Improved biomarker performance Better performed clinical trials Improved AKI outcomes Pre operative cardiac Sx ICU Admission Aminoglycoside start Chemotherapy start Who do we measure biomarkers in? Everyone? When do we measure biomarkers? At ICU admission? After start of drug? 3 days after? How often do we measure biomarker? Every day? Every 12 hours? Cardiac surgery patients at risk for AKI Clinical/biomarker risk profile Low Risk High Risk Standard Care Preventive Rx Active Avoidance Remnant/ongoing Injury dipstick Long-term risk Need follow-up Preventive Rx DISCHARGE AKI Dipstick Treatment AKI Injury Severity Dipstick?Real AKI?Long-term risk?rrt need Overview 1. Pediatric AKI common and associated with poor outcomes 2. Opportunities for AKI biomarkers in children 3. Review of some published pediatric AKI biomarker data 4. Future directions 20

21 Long term follow up studies 21

22 COG LTFU guidelines V 3 Urinary tract References Old data Lack of prospective long term studies THANK YOU GST measurements Colleagues and Collaborators MCH co-investigators R. Gottesman A. Dancea C. Tchervenkov L. Lands U Alberta C. Morgan A. Joffee CHUSJ J Lacroix P Jouvet F Gauvin V Phan ABLE K. Schultz R. Rassekh L. Mitchell M. McBryde G. Cuvelier U Cincinnati P. Devarajan C. Krawczeski S. Goldstein M. Bennett LHSC, Ontario A. Garg Yale C. Parikh S. Coca Z. Wang Harvard J. Bonventre V. Sabissetti THANK YOU MCH Research Team A. Palijan, PhD M. Pizzi J. Caldwell J.A. Doucet, BNSc S. Segal M. Piccioni, MSc P. Lagos-Arevalo M. Harel-Sterling M. Verway, PhD(c) M. Haasz, MD O. Alkandari, MD B. Albright, MD Z. Al-Sani, MD Y. Kazzaz, MD J. Séguin, MD Z. Alismaili, MD 22

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Sepsis and the Clinical Laboratory

Sepsis and the Clinical Laboratory Sepsis and the Clinical Laboratory Alison Woodworth, PhD Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville, TN Learning Objectives Outline the Pathogenesis

More information

CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what

CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what Cardiac surgery induced acute kidney injury and the perfusionist M. Ranucci Director of Clinical Research Dept of Cardiothoracic and Vascular Anesthesia and Intensive Care IRCCS Policlinico S.Donato Ranuuci,

More information

Research Article Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL

Research Article Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL BioMed Research International Volume 2015, Article ID 413751, 8 pages http://dx.doi.org/10.1155/2015/413751 Research Article Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL

More information

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n

More information

AAP Clinical Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children (2011)

AAP Clinical Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children (2011) AAP Clinical Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children (2011) from the Executive Committee Section on Urology American Academy

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE Outline I. Introduction II. Identifying Members with Kidney Disease III. Clinical Guidelines for Kidney Disease A. Chronic Kidney Disease B. End Stage Renal Disease

More information

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California Care of the Post-Cardiac Surgery Patient Lundy J. Campbell, M.D. Associate Professor University of California Post-Operative Issues Post-op atrial fibrillation Acute kidney injury Acute respiratory failure

More information

Conflict of Interest Disclosure Statement. Obstacles. Objectives. Doctor of Nursing Practice. The Perfect Storm

Conflict of Interest Disclosure Statement. Obstacles. Objectives. Doctor of Nursing Practice. The Perfect Storm How to Effectively Institute a Scholarly Inquiry/Research Program in a Practice Doctorate Curriculum Conflict of Interest Disclosure Statement I have no financial relationships with any commercial interest

More information

AKI in Acute Dialysis Units outside ICU across Finland

AKI in Acute Dialysis Units outside ICU across Finland AKI in Acute Dialysis Units outside ICU across Finland Mikko Haapio, MD Consulting Nephrologist Helsinki University Central Hospital Department of Nephrology mikko.haapio@hus.fi FINNAKI-Nephro In conjunction

More information

Albuminuria versus GFR as markers of diabetic CKD progression

Albuminuria versus GFR as markers of diabetic CKD progression Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection

The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection The value of urine protein/creatinine (upcr) and albumin/creatinine ratios (uacr) in assessing renal disease in HIV infection A Samarawickrama, S Holt, K Nambiar, M Fisher, Y Gilleece Brighton and Sussex

More information

Retrospective review of the Modified Early Warning Score in critically ill surgical inpatients at a Canadian Hospital

Retrospective review of the Modified Early Warning Score in critically ill surgical inpatients at a Canadian Hospital Retrospective review of the Modified Early Warning Score in critically ill surgical inpatients at a Canadian Hospital Alisha Mills PGY 4 General Surgery Northern Ontario School of Medicine S Disclosures

More information

Population health management at Cleveland clinic

Population health management at Cleveland clinic Population health management at Cleveland clinic Sankar D Navaneethan, MD, MS, MPH Using Health Information Technology to Identify and Manage CKD Populations Oct 22-23 2015 Objectives Development of an

More information

Group Accident Insurance

Group Accident Insurance Group Accident Insurance An accident insurance plan provides benefits to help cover the costs associated with unexpected bills. This plan pays over and above medical and can purchase without having medical

More information

ENHANCEMENT OF ACUTE SERVICE IN KCC ON CLINICAL PATHWAY FOR GERIATRIC HIP FRACTURE. Elaine Wong WY Queen Elizabeth Hospital 7 May 2012

ENHANCEMENT OF ACUTE SERVICE IN KCC ON CLINICAL PATHWAY FOR GERIATRIC HIP FRACTURE. Elaine Wong WY Queen Elizabeth Hospital 7 May 2012 ENHANCEMENT OF ACUTE SERVICE IN KCC ON CLINICAL PATHWAY FOR GERIATRIC HIP FRACTURE Elaine Wong WY Queen Elizabeth Hospital 7 May 2012 BACKGROUND In KCC, there are around 800 cases admitted for geriatric

More information

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare

More information

Grading of acute kidney injury (2013)

Grading of acute kidney injury (2013) Acute kidney disease represents a spectrum of disease associated with a sudden onset of renal parenchymal injury most typically characterized by generalized failure of the kidneys to meet the excretory,

More information

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations

More information

Acute Renal Failure. usually a consequence.

Acute Renal Failure. usually a consequence. Acute Renal Failure usually a consequence www.philippelefevre.com Definitions Pathogenisis Classification ICU Incidence/ Significance Treatments Prerenal Azotaemia Blood Pressure Cardiopulmonary Baroreceptors

More information

Improving the reporting of Medication Incidents. From Incident Reporting to Controls Assurance

Improving the reporting of Medication Incidents. From Incident Reporting to Controls Assurance Improving the reporting of Medication Incidents From Incident Reporting to Controls Assurance Quote Strive for perfection in everything you do. Take the best that exists and make it better. When it does

More information

Use of Postoperative Creatinine to Predict Sustained Kidney Injury in Patients Undergoing Mesothelioma Surgery

Use of Postoperative Creatinine to Predict Sustained Kidney Injury in Patients Undergoing Mesothelioma Surgery Article Use of Postoperative Creatinine to Predict Sustained Kidney Injury in Patients Undergoing Mesothelioma Surgery K. Annette Mizuguchi,* Aya Mitani,* Sushrut S. Waikar, Peter Ireland, Christia Panizales,

More information

Advanced Clinical Decision Support & Acute Kidney Injury

Advanced Clinical Decision Support & Acute Kidney Injury Advanced Clinical Decision Support & Acute Kidney Injury Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology and Honorary Consultant Physician eprescribing & CDS in Birmingham, UK Jamie Coleman 1

More information

2014 European AKI Diagnostics Market Product Leadership Award

2014 European AKI Diagnostics Market Product Leadership Award 2014 European AKI Diagnostics Market Product Leadership Award Contents Letter of Congratulations... 3 Background and Company Performance... 4 Industry Challenges... 4 Conclusion... 6 Significance of Technology

More information

CKD Model Technical Document

CKD Model Technical Document CKD Model Technical Document This report arises from the project EConDA which has received funding from the European Union in the framework of the Health Programme. Project number: 2012 12 13 Introduction

More information

Ancillary Comparison Charts

Ancillary Comparison Charts Ancillary Comparison Charts ACCIDENT PLANS Accident Plans (Page 1 of 3) STANDARD LIFE AND ACCIDENT Accident Plan Freedom Accidental Death Fraxure Care AME ASSURANT Acci Fixed-Benefit Issue Age 18-74 18-79

More information

Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic

Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic Rehabilitation and Lung Cancer Resection Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic Disclosure Funded by the National Cancer Institute NIH for Preoperative

More information

Human Capital Development & Education Program Proposal

Human Capital Development & Education Program Proposal Human Capital Development & Education Program Proposal Cardiology & Cardiovascular Surgery Emergency Medicine Respiratory Medicine Infection Control HMIS 1 (15 Courses) Module 1/2 1/15 Course Title : Management

More information

Health-Care Associated Infection Rates among Adult Patients in Bahrain Military Hospital: A Cross Sectional Survey

Health-Care Associated Infection Rates among Adult Patients in Bahrain Military Hospital: A Cross Sectional Survey Bahrain Medical Bulletin, Vol. 32, No. 1, March 2010 Health-Care Associated Infection Rates among Adult Patients in Bahrain Military Hospital: A Cross Sectional Survey Kelechi Austin Ofurum, M.Sc, B.Sc*,

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center Modified Early Warning Score (MEWS) Ruchika D. Husa, MD, MS Assistant t Professor of Medicine i in the Division of Cardiology The Ohio State University Wexner Medical Center MEWS Simple physiological scoring

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

Pressure Ulcers in the ICU Incidence, Risk Factors & Prevention

Pressure Ulcers in the ICU Incidence, Risk Factors & Prevention Congress of the Critical Care Society of South Africa Sun City, 10-12 July 2015 Pressure Ulcers in the ICU Incidence, Risk Factors & Prevention Stijn BLOT Dept. of Internal Medicine Faculty of Medicine

More information

Optimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University

Optimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University Optimal fluid therapy in 2013 Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University EGDT: fluids are good & prevent AKI Lin et al, Shock 2006 EGDT and AKI Prowle et

More information

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney

More information

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

NATIONAL CANCER DRUG FUND PRIORITISATION SCORES

NATIONAL CANCER DRUG FUND PRIORITISATION SCORES NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication Regimen (where appropriate) BORTEZOMIB In combination with dexamethasone (VD), or with dexamethasone and thalidomide (VTD), is indicated

More information

Inhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump

Inhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump Chris J. Taylor, Pharm.D., BCPS Clinical Pharmacist Phoenix VA Health Care System Review pharmacology of PPIs Discuss possible association between PPI use and development of the following: Pneumonia (community-acquired

More information

Impact of Early Renal Recovery on Survival After Cardiac Surgery-Associated Acute Kidney Injury

Impact of Early Renal Recovery on Survival After Cardiac Surgery-Associated Acute Kidney Injury CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS

More information

BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN

BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN R. Phillip Dellinger MD, MSc, MCCM Professor of Medicine Cooper Medical School of Rowan University Professor of Medicine University Medicine and Dentistry of

More information

Little Ado (yet) About Much (money)

Little Ado (yet) About Much (money) The Concentration of Health Care Spending: Little Ado (yet) About Much (money) Walter P Wodchis Peter Austin, Alice Newman, Ashley Corallo, David Henry Institute for Clinical Evaluative Sciences CAHSPR

More information

Relapsed or Refractory Adult Acute Lymphoblastic Leukemia (ALL): Distinct Patient Populations With Significant Unmet Medical Need

Relapsed or Refractory Adult Acute Lymphoblastic Leukemia (ALL): Distinct Patient Populations With Significant Unmet Medical Need Relapsed or Refractory Adult Acute Lymphoblastic Leukemia (ALL): Distinct Patient Populations With Significant Unmet Medical Need Hagop M. Kantarjian, MD Chairman, Leukemia Department Department of Hematology

More information

Peter Munk Cardiac Centre, University Health Network. Allied Health Personnel Symposium American Association of Thoracic Surgery April 26, 2014

Peter Munk Cardiac Centre, University Health Network. Allied Health Personnel Symposium American Association of Thoracic Surgery April 26, 2014 The Expanding Role of the Nurse Practitioner and Physician Assistant Across the Continuum of Care for the CTS Patient: Preoperative, Postoperative, and After Discharge Jane MacIver RN NP PhD Peter Munk

More information

Information for Childhood Cancer Survivors. Kidney Problems

Information for Childhood Cancer Survivors. Kidney Problems Kidney problems Some chemotherapy drugs can affect the kidneys. The kidneys break down and remove many chemotherapy drugs from the body. When chemotherapy drugs get broken down, they may make products

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

GUIDELINE FOR STEP-DOWN TRANSFER OF PATIENTS FROM CRITICAL CARE AREAS

GUIDELINE FOR STEP-DOWN TRANSFER OF PATIENTS FROM CRITICAL CARE AREAS GUIDELINE FOR STEP-DOWN TRANSFER OF PATIENTS FROM CRITICAL CARE AREAS This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential

More information

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal

More information

Diagnose und Therapie: Akutes Nierenversagen. Abteilung Nephrologie und und Hypertensiologie

Diagnose und Therapie: Akutes Nierenversagen. Abteilung Nephrologie und und Hypertensiologie Diagnose und Therapie: Akutes Nierenversagen Jan Jan T. T. Kielstein Abteilung Nephrologie und und Hypertensiologie MHH MHH Diagnose und Therapie: Akutes Nierenversagen 1) Definition ANV/ Acute kidney

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

Pain Management in the Critically ill Patient

Pain Management in the Critically ill Patient Pain Management in the Critically ill Patient Jim Ducharme MD CM, FRCP President-Elect, IFEM Clinical Professor of Medicine, McMaster University Adjunct Professor of Family Medicine, Queens University

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population

Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population Intensive Care Med DOI 10.1007/s00134-009-1711-1 ORIGINAL Dinna N. Cruz Massimo de Cal Francesco Garzotto Mark A. Perazella Paolo Lentini Valentina Corradi Pasquale Piccinni Claudio Ronco Plasma neutrophil

More information

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3

More information

Dr. Geoff Cuvelier. Pediatric Oncologist MD FRCPC

Dr. Geoff Cuvelier. Pediatric Oncologist MD FRCPC Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the

More information

PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY

PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

Application of Engineering Principles to Patient Flow & Healthcare Delivery

Application of Engineering Principles to Patient Flow & Healthcare Delivery Application of Engineering Principles to Patient Flow & Healthcare Delivery Jeanne M Huddleston, MD, MS Medical Director, Health Care Systems Engineering Mayo Clinic 2013 MFMER slide-1 2013 MFMER slide-2

More information

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy

More information

Update in Contrast Induced Nephropathy

Update in Contrast Induced Nephropathy Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina

More information

St Vincent s Hospital Sydney Referral to Sacred Heart Rehabilitation Consultation Service Policy Section 1 Policy 32

St Vincent s Hospital Sydney Referral to Sacred Heart Rehabilitation Consultation Service Policy Section 1 Policy 32 Subject: Referral to the Sacred Heart Rehabilitation Consultation Service Area: Hospital wide Classification: Operational Relevant to: All clinical staff Implementation date: October 2003 Review Date:

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal

4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal Background 1 Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Alyssa Cavanaugh, PharmD PGY1 Pharmacy Resident Children s Hospital of Michigan **The speaker has no actual or

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Use of a Soft Silicone Bordered Sacrum Dressing to Reduce Pressure Ulcer Formation in Critically Ill Patients: A Randomized Clinical Trial

Use of a Soft Silicone Bordered Sacrum Dressing to Reduce Pressure Ulcer Formation in Critically Ill Patients: A Randomized Clinical Trial Use of a Soft Silicone Bordered Sacrum Dressing to Reduce Pressure Ulcer Formation in Critically Ill Patients: A Randomized Clinical Trial Peggy Kalowes RN, PhD, CNS, FAHA Principal Investigator Director,

More information

STUDY PROTOCOL. Fabio Ciceri M.D. Istituto Scientifico H. San Raffaele Dept. of of Oncology, Haematology/Transplant Unit I-20132 Milan

STUDY PROTOCOL. Fabio Ciceri M.D. Istituto Scientifico H. San Raffaele Dept. of of Oncology, Haematology/Transplant Unit I-20132 Milan STUDY PROTOCOL Clinical phase II trial to evaluate the safety and efficacy of treosulfan combined with cytarabine and fludarabine prior to autologous haematopoietic stem cell transplantation in elderly

More information

Using Medicare Hospitalization Information and the MedPAR. Beth Virnig, Ph.D. Associate Dean for Research and Professor University of Minnesota

Using Medicare Hospitalization Information and the MedPAR. Beth Virnig, Ph.D. Associate Dean for Research and Professor University of Minnesota Using Medicare Hospitalization Information and the MedPAR Beth Virnig, Ph.D. Associate Dean for Research and Professor University of Minnesota MedPAR Medicare Provider Analysis and Review Includes information

More information

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.

More information

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries 1. Authors James H. McMahon Alfred Hospital, Melbourne, Australia

More information

What factors determine poor functional outcome following Total Knee Replacement (TKR)?

What factors determine poor functional outcome following Total Knee Replacement (TKR)? Specific Question: What factors determine poor functional outcome following Total Knee Replacement ()? Clinical bottom line All groups derived benefit from undergoing a, reviews suggests that the decision

More information

Trends in Life Expectancy and Causes of Death Following Spinal Cord Injury. Michael J. DeVivo, Dr.P.H.

Trends in Life Expectancy and Causes of Death Following Spinal Cord Injury. Michael J. DeVivo, Dr.P.H. Trends in Life Expectancy and Causes of Death Following Spinal Cord Injury Michael J. DeVivo, Dr.P.H. Disclosure of PI-RRTC Grant James S. Krause, PhD, Holly Wise, PhD; PT, and Emily Johnson, MHA have

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

VASOPRESSOR AGENTS IN SEPTIC SHOCK

VASOPRESSOR AGENTS IN SEPTIC SHOCK VASOPRESSOR AGENTS IN SEPTIC SHOCK Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles President European Society of Intensive

More information

Electronic Health Record Identification of Nephrotoxin Exposure and Associated Acute Kidney Injury

Electronic Health Record Identification of Nephrotoxin Exposure and Associated Acute Kidney Injury Electronic Health Record Identification of Nephrotoxin Exposure and Associated Acute Kidney Injury abstract BACKGROUND AND OBJECTIVE: Nephrotoxic medication exposure represents a common cause of acute

More information

Chronic Kidney Disease (CKD) Getting it right from the start

Chronic Kidney Disease (CKD) Getting it right from the start Chronic Kidney Disease (CKD) Getting it right from the start Increased demand for ESRF Treatment 2007 NZ No of patients on dialysis - 2064 New Patients 461 41% - Type II Diabetes 20% were late referrals

More information

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) Protocol Code Tumour Group Contact Physician UGUTIP Genitourinary Dr.

More information

Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014

Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014 Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014 Ryan Arnold, MD Department of Emergency Medicine and Value Institute Christiana Care Health System, Newark, DE Susan Niemeier, RN Chief Nursing

More information

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <...

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <... National Clinical Guideline Centre Draft for consultation Preoperative tests Routine preoperative tests for elective surgery Clinical guideline Appendix N: Research recommendations October 2015 Draft

More information

Individual Prediction

Individual Prediction Individual Prediction Michael W. Kattan, Ph.D. Professor of Medicine, Epidemiology and Biostatistics, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Chairman, Department

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano CIN (CI-AKI) definition Both clinical studies and ESUR definition (Thomsen

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

The 4Kscore blood test for risk of aggressive prostate cancer

The 4Kscore blood test for risk of aggressive prostate cancer The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6

More information

Your patient has had one too many of these. What would you do? a.observe the patient. b.give intravenous fluids.

Your patient has had one too many of these. What would you do? a.observe the patient. b.give intravenous fluids. Your patient has had one too many of these. What would you do? a.observe the patient. b.give intravenous fluids. Does IV saline therapy reduce alcohol intoxication in the ED? ACEM 4.10 Trainee Research

More information

Sepsis: Identification and Treatment

Sepsis: Identification and Treatment Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge

More information

PAIN MEDICINES AND YOUR KIDNEYS

PAIN MEDICINES AND YOUR KIDNEYS PAIN MEDICINES AND YOUR KIDNEYS What You Need to Know www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease

More information

KDIGO CLINICAL PRACTICE GUIDELINE FOR ACUTE KIDNEY INJURY

KDIGO CLINICAL PRACTICE GUIDELINE FOR ACUTE KIDNEY INJURY KDIGO CLINICAL PRACTICE GUIDELINE FOR ACUTE KIDNEY INJURY Online Appendices A-F March 2012 Online Appendices A-F 1 TABLE OF CONTENTS Abbreviations and Acronyms... 5 Appendix A: Background... 7 Appendix

More information

Underwriting Methods and Chronic Conditions. All you need to know about cover for pre-existing and chronic conditions

Underwriting Methods and Chronic Conditions. All you need to know about cover for pre-existing and chronic conditions Underwriting Methods and Chronic Conditions All you need to know about cover for pre-existing and chronic conditions Contents Page number Introduction 3 A choice of ways to apply 4 How we deal with chronic

More information

Using the Electronic Medical Record to Improve Evidence-based Medical Practice. P. Brian Smith Duke University Medical Center Durham, NC

Using the Electronic Medical Record to Improve Evidence-based Medical Practice. P. Brian Smith Duke University Medical Center Durham, NC Using the Electronic Medical Record to Improve Evidence-based Medical Practice P. Brian Smith Duke University Medical Center Durham, NC Disclosure I have no relevant financial relationships with the manufacturer

More information

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized

More information

renal transplantation: A single-center comparative study

renal transplantation: A single-center comparative study Impact of posterior urethral valves on pediatric renal transplantation: A single-center comparative study BY Mohamed Kamal Gheith, MD Oberarzt die Urologie, Universitätsmedizin Mainz Ass. Prof. of Urology,

More information

Five things to watch in nephrology. David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine

Five things to watch in nephrology. David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine Five things to watch in nephrology David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine Financial Disclosures David Sheikh-Hamad, MD In the context of my

More information

in the Elderly Thomas Robinson, MD Surgery Grand Rounds March 10 th, 2008

in the Elderly Thomas Robinson, MD Surgery Grand Rounds March 10 th, 2008 Post- Operative Delirium in the Elderly Thomas Robinson, MD Surgery Grand Rounds March 10 th, 2008 What is the most common post-operative complication in elderly patients? What is the most common post-operative

More information